Plasma‐derived factor VIIa and factor X mixture agent (MC710) prophylaxis in haemophilia B patients with inhibitorsMichio Sakai, Akira Shirahata, Hiroyuki Ishida et al.|Haemophilia|2022Cited by 5
Sub analysis of Japanese patients with hemophilia B in rIX-FP clinical trialAzusa Nagao, Michio Sakai, Hideji Hanabusa et al.|Japanese Journal of Thrombosis and Hemostasis|2017Cited by 0